nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—larynx—esophageal cancer	0.0691	0.191	CbGeAlD
Nedocromil—HSP90AA1—exocrine gland—esophageal cancer	0.0287	0.0792	CbGeAlD
Nedocromil—FPR1—digestive system—esophageal cancer	0.0261	0.0723	CbGeAlD
Nedocromil—PTGDR—digestive system—esophageal cancer	0.0247	0.0683	CbGeAlD
Nedocromil—CYSLTR2—lung—esophageal cancer	0.0242	0.067	CbGeAlD
Nedocromil—FPR1—lung—esophageal cancer	0.0218	0.0604	CbGeAlD
Nedocromil—PTGDR—lung—esophageal cancer	0.0206	0.057	CbGeAlD
Nedocromil—HSP90AA1—neck—esophageal cancer	0.0183	0.0507	CbGeAlD
Nedocromil—CYSLTR1—bronchus—esophageal cancer	0.0141	0.0391	CbGeAlD
Nedocromil—PTGDR—lymph node—esophageal cancer	0.0141	0.039	CbGeAlD
Nedocromil—CYSLTR1—smooth muscle tissue—esophageal cancer	0.0138	0.0383	CbGeAlD
Nedocromil—HSP90AA1—epithelium—esophageal cancer	0.0125	0.0345	CbGeAlD
Nedocromil—HSP90AA1—bronchus—esophageal cancer	0.0123	0.0339	CbGeAlD
Nedocromil—HSP90AA1—smooth muscle tissue—esophageal cancer	0.012	0.0332	CbGeAlD
Nedocromil—HSP90AA1—trachea—esophageal cancer	0.011	0.0305	CbGeAlD
Nedocromil—HSP90AA1—digestive system—esophageal cancer	0.00948	0.0262	CbGeAlD
Nedocromil—CYSLTR1—lung—esophageal cancer	0.00913	0.0252	CbGeAlD
Nedocromil—HSP90AA1—lung—esophageal cancer	0.00792	0.0219	CbGeAlD
Nedocromil—CYSLTR1—lymph node—esophageal cancer	0.00624	0.0173	CbGeAlD
Nedocromil—HSP90AA1—lymph node—esophageal cancer	0.00542	0.015	CbGeAlD
Nedocromil—CYSLTR2—Signaling Pathways—CTNNA1—esophageal cancer	0.000317	0.000497	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CXCL2—esophageal cancer	0.000315	0.000494	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—SMAD4—esophageal cancer	0.000313	0.00049	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—CDKN2A—esophageal cancer	0.000302	0.000474	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ELMO1—esophageal cancer	0.000299	0.000468	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—EGFR—esophageal cancer	0.000295	0.000462	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PSME2—esophageal cancer	0.000294	0.000461	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PSME1—esophageal cancer	0.000294	0.000461	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ANXA1—esophageal cancer	0.000293	0.000459	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—GSTO1—esophageal cancer	0.000292	0.000458	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TPI1—esophageal cancer	0.000292	0.000458	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CFL1—esophageal cancer	0.000292	0.000458	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ELMO1—esophageal cancer	0.000292	0.000457	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TGFBR2—esophageal cancer	0.000292	0.000457	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—WWOX—esophageal cancer	0.00029	0.000455	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000286	0.000447	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—ABL1—esophageal cancer	0.000285	0.000447	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKAP13—esophageal cancer	0.000285	0.000447	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SST—esophageal cancer	0.000285	0.000447	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ADH1B—esophageal cancer	0.000283	0.000444	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TGFBR2—esophageal cancer	0.000282	0.000441	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ALDOB—esophageal cancer	0.00028	0.000439	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—LGALS3—esophageal cancer	0.00028	0.000438	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—GHRL—esophageal cancer	0.000278	0.000435	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NOTCH3—esophageal cancer	0.000278	0.000435	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FKBP1A—esophageal cancer	0.000276	0.000433	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—SMAD4—esophageal cancer	0.000276	0.000432	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—FBXW7—esophageal cancer	0.000273	0.000428	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—EGFR—esophageal cancer	0.000271	0.000425	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TYMP—esophageal cancer	0.000271	0.000424	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—WIF1—esophageal cancer	0.00027	0.000423	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HIST1H2BM—esophageal cancer	0.00027	0.000422	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—GAPDH—esophageal cancer	0.00027	0.000422	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—SMAD4—esophageal cancer	0.000267	0.000418	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP26A1—esophageal cancer	0.000263	0.000412	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000263	0.000412	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PDE4D—esophageal cancer	0.000261	0.000408	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ALOX15—esophageal cancer	0.000257	0.000402	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—PIK3CA—esophageal cancer	0.000256	0.000401	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NOTCH2—esophageal cancer	0.000249	0.00039	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000249	0.00039	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ACTB—esophageal cancer	0.000248	0.000389	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GNG7—esophageal cancer	0.000248	0.000388	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—CDKN1A—esophageal cancer	0.000247	0.000387	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—ERBB2—esophageal cancer	0.000246	0.000385	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—KDR—esophageal cancer	0.000245	0.000384	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TPI1—esophageal cancer	0.000245	0.000383	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTO1—esophageal cancer	0.000245	0.000383	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PTPN2—esophageal cancer	0.000243	0.00038	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—B2M—esophageal cancer	0.00024	0.000376	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—MET—esophageal cancer	0.00024	0.000375	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—XIAP—esophageal cancer	0.000238	0.000373	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—PIK3CA—esophageal cancer	0.000235	0.000369	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—EP300—esophageal cancer	0.000235	0.000368	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ALDOB—esophageal cancer	0.000235	0.000368	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PFN1—esophageal cancer	0.000233	0.000365	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—XIAP—esophageal cancer	0.000232	0.000364	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—NOTCH1—esophageal cancer	0.000231	0.000361	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PSME2—esophageal cancer	0.000227	0.000355	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PSME1—esophageal cancer	0.000227	0.000355	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HIF1A—esophageal cancer	0.000226	0.000354	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GAPDH—esophageal cancer	0.000226	0.000354	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HSPA5—esophageal cancer	0.000224	0.000352	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CRABP1—esophageal cancer	0.000224	0.000351	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—B2M—esophageal cancer	0.000221	0.000347	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TGFBR2—esophageal cancer	0.000221	0.000346	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CTNNA1—esophageal cancer	0.00022	0.000344	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CXCL2—esophageal cancer	0.000218	0.000342	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HIF1A—esophageal cancer	0.000218	0.000342	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CALR—esophageal cancer	0.000217	0.000341	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—TLR4—esophageal cancer	0.000216	0.000339	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—KDR—esophageal cancer	0.000216	0.000338	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—RB1—esophageal cancer	0.000216	0.000338	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GNG7—esophageal cancer	0.000213	0.000333	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ENO1—esophageal cancer	0.000212	0.000333	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—FBXW7—esophageal cancer	0.00021	0.000329	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ELMO1—esophageal cancer	0.000209	0.000328	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—SMAD4—esophageal cancer	0.000209	0.000328	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PSME1—esophageal cancer	0.000209	0.000328	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PSME2—esophageal cancer	0.000209	0.000328	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—CREBBP—esophageal cancer	0.000209	0.000328	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—KDR—esophageal cancer	0.000209	0.000327	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKAP13—esophageal cancer	0.000205	0.000321	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PSME2—esophageal cancer	0.000204	0.00032	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PSME1—esophageal cancer	0.000204	0.00032	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NOTCH1—esophageal cancer	0.000204	0.000319	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ANXA1—esophageal cancer	0.000203	0.000318	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HMGB1—esophageal cancer	0.000201	0.000315	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CALR—esophageal cancer	0.000201	0.000314	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ALDH2—esophageal cancer	0.000199	0.000312	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SST—esophageal cancer	0.000198	0.00031	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NOTCH1—esophageal cancer	0.000197	0.000308	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—FBXW7—esophageal cancer	0.000194	0.000304	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—RB1—esophageal cancer	0.000193	0.000302	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GHRL—esophageal cancer	0.000193	0.000302	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOTCH3—esophageal cancer	0.000193	0.000302	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GSTT1—esophageal cancer	0.00019	0.000297	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—esophageal cancer	0.00019	0.000297	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—FBXW7—esophageal cancer	0.000189	0.000297	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000189	0.000296	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP2A6—esophageal cancer	0.000188	0.000294	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PDE4D—esophageal cancer	0.000187	0.000293	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CASP8—esophageal cancer	0.000186	0.000291	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CREBBP—esophageal cancer	0.000185	0.000289	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CREBBP—esophageal cancer	0.000185	0.000289	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—EGFR—esophageal cancer	0.000181	0.000284	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CREBBP—esophageal cancer	0.000178	0.000279	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GNG7—esophageal cancer	0.000178	0.000279	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS1—esophageal cancer	0.000178	0.000279	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ENO1—esophageal cancer	0.000178	0.000279	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PSME1—esophageal cancer	0.000175	0.000274	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PSME2—esophageal cancer	0.000175	0.000274	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—ERBB2—esophageal cancer	0.000175	0.000274	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—EGFR—esophageal cancer	0.000175	0.000274	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000173	0.000271	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOTCH2—esophageal cancer	0.000173	0.000271	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HIF1A—esophageal cancer	0.000171	0.000268	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—EGFR—esophageal cancer	0.00017	0.000267	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDKN2A—esophageal cancer	0.00017	0.000266	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—esophageal cancer	0.000168	0.000264	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000167	0.000262	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—XIAP—esophageal cancer	0.000167	0.000261	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ABL1—esophageal cancer	0.000166	0.00026	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NOS3—esophageal cancer	0.000165	0.000259	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KDR—esophageal cancer	0.000164	0.000256	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CCND1—esophageal cancer	0.00016	0.000251	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NOS3—esophageal cancer	0.00016	0.00025	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—BCL2—esophageal cancer	0.000159	0.000249	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CTNNA1—esophageal cancer	0.000158	0.000247	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000157	0.000247	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—TGFBR2—esophageal cancer	0.000157	0.000246	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CXCL2—esophageal cancer	0.000157	0.000246	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDKN1A—esophageal cancer	0.000155	0.000243	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—ERBB2—esophageal cancer	0.000155	0.000242	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ERBB2—esophageal cancer	0.000155	0.000242	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NOTCH1—esophageal cancer	0.000154	0.000242	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TGFBR2—esophageal cancer	0.000153	0.00024	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—PIK3CA—esophageal cancer	0.000152	0.000238	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP1B1—esophageal cancer	0.000151	0.000237	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ERBB2—esophageal cancer	0.000149	0.000234	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—SMAD4—esophageal cancer	0.000149	0.000233	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—EP300—esophageal cancer	0.000148	0.000231	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PSME1—esophageal cancer	0.000146	0.000229	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PSME2—esophageal cancer	0.000146	0.000229	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ANXA1—esophageal cancer	0.000146	0.000228	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—SMAD4—esophageal cancer	0.000145	0.000227	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CCND1—esophageal cancer	0.000143	0.000224	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EP300—esophageal cancer	0.000142	0.000223	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CYP19A1—esophageal cancer	0.000142	0.000223	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SST—esophageal cancer	0.000142	0.000222	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CREBBP—esophageal cancer	0.00014	0.000219	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDKN1A—esophageal cancer	0.000139	0.000217	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GHRL—esophageal cancer	0.000138	0.000217	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOTCH3—esophageal cancer	0.000138	0.000217	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—EGFR—esophageal cancer	0.000137	0.000215	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CCND1—esophageal cancer	0.000137	0.000214	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—FBXW7—esophageal cancer	0.000136	0.000213	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CDKN1A—esophageal cancer	0.000132	0.000207	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CDKN1A—esophageal cancer	0.000132	0.000207	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—EP300—esophageal cancer	0.000132	0.000207	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CCND1—esophageal cancer	0.000132	0.000207	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000131	0.000206	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HMOX1—esophageal cancer	0.00013	0.000203	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MYC—esophageal cancer	0.000129	0.000201	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CDKN1A—esophageal cancer	0.000128	0.0002	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—TLR4—esophageal cancer	0.000126	0.000197	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EP300—esophageal cancer	0.000126	0.000197	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EP300—esophageal cancer	0.000126	0.000197	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NOS3—esophageal cancer	0.000125	0.000196	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ABCB1—esophageal cancer	0.000124	0.000195	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOTCH2—esophageal cancer	0.000124	0.000194	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HIF1A—esophageal cancer	0.000122	0.000191	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—EGFR—esophageal cancer	0.000121	0.00019	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EP300—esophageal cancer	0.000121	0.00019	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—PIK3CA—esophageal cancer	0.000119	0.000187	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HIF1A—esophageal cancer	0.000119	0.000186	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ERBB2—esophageal cancer	0.000117	0.000183	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MYC—esophageal cancer	0.000115	0.00018	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KDR—esophageal cancer	0.000113	0.000178	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS2—esophageal cancer	0.000111	0.000173	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TGFBR2—esophageal cancer	0.00011	0.000172	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOTCH1—esophageal cancer	0.00011	0.000172	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MYC—esophageal cancer	0.00011	0.000172	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CASP8—esophageal cancer	0.000108	0.000169	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CREBBP—esophageal cancer	0.000108	0.000169	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—EGFR—esophageal cancer	0.000107	0.000168	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—EGFR—esophageal cancer	0.000107	0.000168	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOTCH1—esophageal cancer	0.000107	0.000167	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MYC—esophageal cancer	0.000106	0.000166	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—SMAD4—esophageal cancer	0.000104	0.000163	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CCND1—esophageal cancer	0.000103	0.000162	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—EGFR—esophageal cancer	0.000103	0.000162	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CDKN1A—esophageal cancer	0.0001	0.000157	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CREBBP—esophageal cancer	9.94e-05	0.000156	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CREBBP—esophageal cancer	9.69e-05	0.000152	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—EGFR—esophageal cancer	9.52e-05	0.000149	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EP300—esophageal cancer	9.52e-05	0.000149	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—esophageal cancer	9.44e-05	0.000148	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PIK3CA—esophageal cancer	9.31e-05	0.000146	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PIK3CA—esophageal cancer	9.3e-05	0.000146	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—BCL2—esophageal cancer	9.28e-05	0.000145	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—PIK3CA—esophageal cancer	9.1e-05	0.000143	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ERBB2—esophageal cancer	9.01e-05	0.000141	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—esophageal cancer	8.99e-05	0.000141	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PIK3CA—esophageal cancer	8.98e-05	0.000141	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NOS3—esophageal cancer	8.9e-05	0.000139	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—esophageal cancer	8.69e-05	0.000136	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NOS3—esophageal cancer	8.68e-05	0.000136	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HIF1A—esophageal cancer	8.52e-05	0.000133	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—CREBBP—esophageal cancer	8.32e-05	0.00013	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ERBB2—esophageal cancer	8.32e-05	0.00013	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MYC—esophageal cancer	8.3e-05	0.00013	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PIK3CA—esophageal cancer	8.27e-05	0.000129	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KDR—esophageal cancer	8.15e-05	0.000128	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTGS2—esophageal cancer	8.14e-05	0.000127	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ERBB2—esophageal cancer	8.12e-05	0.000127	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—EGFR—esophageal cancer	8.12e-05	0.000127	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—CDKN1A—esophageal cancer	7.7e-05	0.000121	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOTCH1—esophageal cancer	7.67e-05	0.00012	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NOS3—esophageal cancer	7.45e-05	0.000117	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EP300—esophageal cancer	7.33e-05	0.000115	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CCND1—esophageal cancer	7.17e-05	0.000112	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—CDKN1A—esophageal cancer	7.11e-05	0.000111	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PIK3CA—esophageal cancer	7.05e-05	0.00011	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CREBBP—esophageal cancer	6.96e-05	0.000109	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CDKN1A—esophageal cancer	6.94e-05	0.000109	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—esophageal cancer	6.82e-05	0.000107	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PTGS2—esophageal cancer	6.81e-05	0.000107	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EP300—esophageal cancer	6.77e-05	0.000106	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EP300—esophageal cancer	6.6e-05	0.000103	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—EGFR—esophageal cancer	6.25e-05	9.79e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NOS3—esophageal cancer	6.23e-05	9.76e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MYC—esophageal cancer	5.9e-05	9.24e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ERBB2—esophageal cancer	5.83e-05	9.13e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—EGFR—esophageal cancer	5.77e-05	9.03e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MYC—esophageal cancer	5.75e-05	9.01e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—EP300—esophageal cancer	5.67e-05	8.88e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—EGFR—esophageal cancer	5.63e-05	8.81e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PIK3CA—esophageal cancer	5.42e-05	8.49e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CCND1—esophageal cancer	5.15e-05	8.06e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PIK3CA—esophageal cancer	5.01e-05	7.84e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CDKN1A—esophageal cancer	4.98e-05	7.8e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PIK3CA—esophageal cancer	4.88e-05	7.65e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EP300—esophageal cancer	4.74e-05	7.42e-05	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—esophageal cancer	4.72e-05	7.4e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PIK3CA—esophageal cancer	4.19e-05	6.57e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MYC—esophageal cancer	4.13e-05	6.47e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—EGFR—esophageal cancer	4.04e-05	6.33e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PIK3CA—esophageal cancer	3.51e-05	5.49e-05	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—esophageal cancer	3.39e-05	5.31e-05	CbGpPWpGaD
